Taking advantage of technology, highlights from the Committee for Medicinal Products for Human Use (CHMP) meetings can now be viewed online through the European Medicines Agency (EMA) website. The first meeting to have highlights available online can be seen here, from the September 19-22 assembly.
In a press release, the EMA indicated the new format would let users view, ”the main opinions adopted at the meeting, along with information on safety reviews, in a clear tabular format.” Individual press releases and other documents will also be available via links through the online meeting summary.
A new web page will be submitted after each month’s CHMP meeting.
Users can voice their opinion about the new format here. Any changes to the new design will be made in early 2012.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.